Palisade Bio (PALI) Other Non-Current Assets (2010 - 2026)
Palisade Bio (PALI) reported Other Non-Current Assets of $17000.0 for Q1 2026, down 34.62% year-over-year from $26000.0 in Q1 2025, and down 75.0% quarter-over-quarter from $68000.0 in Q4 2025.
Palisade Bio (PALI) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Other Non-Current Assets data on file, last reported at $17000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $17000.0, down 34.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $17000.0 (down 34.62% YoY), and the FY2025 annual result was $68000.0, up 161.54% from the prior year.
- Other Non-Current Assets declined to $17000.0 in Q1 2026 per PALI's latest filing, from $68000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $746000.0 in Q3 2022 and troughed at $12000.0 in Q4 2023.
- A 5-year average of $127937.5 and a median of $26000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets surged 2769.23% in 2022, then slumped 97.26% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $26000.0 in 2022, then slumped by 53.85% to $12000.0 in 2023, then surged by 116.67% to $26000.0 in 2024, then surged by 161.54% to $68000.0 in 2025, then sank by 75.0% to $17000.0 in 2026.
- Business Quant data shows PALI's Other Non-Current Assets at $17000.0 in Q1 2026, $68000.0 in Q4 2025, and $171000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 68,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 375,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 438,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 26,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 746,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 868,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 26,000.00 |
| Mar 31, 2021 | 860,702.00 |